{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:43:02Z","timestamp":1790502182994,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T00:00:00Z","timestamp":1599523200000},"content-version":"vor","delay-in-days":1103,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R35 HL135833"],"award-info":[{"award-number":["R35 HL135833"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["1UL1 TR001873"],"award-info":[{"award-number":["1UL1 TR001873"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["KL2 TR001874"],"award-info":[{"award-number":["KL2 TR001874"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1194\/jlr.r077693","type":"journal-article","created":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T00:50:14Z","timestamp":1500425414000},"page":"1756-1764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["The metabolism of lipoprotein (a): an ever-evolving story"],"prefix":"10.1016","volume":"58","author":[{"given":"Gissette","family":"Reyes-Soffer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry N.","family":"Ginsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajasekhar","family":"Ramakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.R077693_bib1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1699-0463.1963.tb01808.x","article-title":"A new serum type system in man-the LP system","volume":"59","author":"Berg","year":"1963","journal-title":"Acta Pathol. Microbiol. Scand."},{"key":"10.1194\/jlr.R077693_bib2","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1194\/jlr.E066985","article-title":"Lipoprotein (a): coming of age at last","volume":"57","author":"Witztum","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R077693_bib3","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/330132a0","article-title":"cDNA sequence of human apolipoprotein(a) is homologous to plasminogen","volume":"330","author":"McLean","year":"1987","journal-title":"Nature."},{"key":"10.1194\/jlr.R077693_bib4","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1172\/JCI115855","article-title":"Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations","volume":"90","author":"Boerwinkle","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R077693_bib5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00041433-199904000-00007","article-title":"Genetic architecture and evolution of the lipoprotein(a) trait","volume":"10","author":"Utermann","year":"1999","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1194\/jlr.R077693_bib6","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1172\/JCI113093","article-title":"Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma","volume":"80","author":"Utermann","year":"1987","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R077693_bib7","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/BF00201550","article-title":"Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups","volume":"86","author":"Sandholzer","year":"1991","journal-title":"Hum. Genet."},{"key":"10.1194\/jlr.R077693_bib8","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1194\/jlr.R067314","article-title":"Structure, function, and genetics of lipoprotein (a)","volume":"57","author":"Schmidt","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R077693_bib9","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1089\/met.2011.0026","article-title":"Lipoprotein(a): genotype-phenotype relationship and impact on atherogenic risk","volume":"9","author":"Enkhmaa","year":"2011","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"10.1194\/jlr.R077693_bib10","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1161\/01.CIR.102.10.1082","article-title":"Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies","volume":"102","author":"Danesh","year":"2000","journal-title":"Circulation."},{"key":"10.1194\/jlr.R077693_bib11","series-title":"Hidden Causesof Heart Attack and Stroke: Inflammation, Cardiology's New Frontier","first-page":"182","article-title":"LP (a) risk factor # IV, inherited","author":"Wilde","year":"2003"},{"key":"10.1194\/jlr.R077693_bib12","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","author":"Emerging Risk Factors Collaboration","year":"2009","journal-title":"JAMA."},{"key":"10.1194\/jlr.R077693_bib13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0022-2275(20)42092-9","article-title":"Quantification of apo[a] and apoB in human atherosclerotic lesions","volume":"32","author":"Pepin","year":"1991","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R077693_bib14","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0022-2275(20)39699-1","article-title":"Partial characterization of lipoproteins containing apo[a] in human atherosclerotic lesions","volume":"34","author":"Hoff","year":"1993","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R077693_bib15","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with Lp(a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.R077693_bib16","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1161\/ATVBAHA.116.308271","article-title":"Estimating the population impact of Lp(a) lowering on the incidence of myocardial infarction and aortic stenosis-brief report","volume":"36","author":"Afshar","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.R077693_bib17","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1194\/jlr.R071233","article-title":"Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology","volume":"57","author":"Nordestgaard","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R077693_bib18","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S2213-8587(17)30088-8","article-title":"Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a Mendelian randomisation analysis","volume":"5","author":"Saleheen","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1194\/jlr.R077693_bib19","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1109034","article-title":"Genetic associations with valvular calcification and aortic stenosis","volume":"368","author":"Thanassoulis","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.R077693_bib20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00041433-199906000-00010","article-title":"The seventh myth of lipoprotein(a): where and how is it assembled?","volume":"10","author":"Dieplinger","year":"1999","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1194\/jlr.R077693_bib21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00041433-200404000-00009","article-title":"Structure-function relationships in apolipoprotein(a): insights into lipoprotein(a) assembly and pathogenicity","volume":"15","author":"Koschinsky","year":"2004","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1194\/jlr.R077693_bib22","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/CIRCRESAHA.116.310272","article-title":"Recycling of apolipoprotein(a) after PlgRKT-mediated endocytosis of lipoprotein(a)","volume":"120","author":"Sharma","year":"2017","journal-title":"Circ. Res."},{"key":"10.1194\/jlr.R077693_bib23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/MOL.0000000000000070","article-title":"Lipoprotein(a) metabolism","volume":"25","author":"Lamon-Fava","year":"2014","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1194\/jlr.R077693_bib24","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1042\/bst0270439","article-title":"Lipoprotein(a): the really bad cholesterol?","volume":"27","author":"Dieplinger","year":"1999","journal-title":"Biochem. Soc. Trans."},{"key":"10.1194\/jlr.R077693_bib25","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.metabol.2012.07.024","article-title":"Lipoprotein(a) metabolism: potential sites for therapeutic targets","volume":"62","author":"Hoover-Plow","year":"2013","journal-title":"Metabolism."},{"key":"10.1194\/jlr.R077693_bib26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0009-3084(94)90131-7","article-title":"Intracellular processing of apo(a) in primary baboon hepatocytes","volume":"67\u201368","author":"White","year":"1994","journal-title":"Chem. Phys. Lipids."},{"key":"10.1194\/jlr.R077693_bib27","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.1021\/bi972761t","article-title":"Intracellular metabolism of human apolipoprotein(a) in stably transfected Hep G2 cells","volume":"37","author":"Lobentanz","year":"1998","journal-title":"Biochemistry."},{"key":"10.1194\/jlr.R077693_bib28","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.1074\/jbc.272.9.5659","article-title":"Expression of a recombinant apolipoprotein(a) in HepG2 cells. Evidence for intracellular assembly of lipoprotein(a)","volume":"272","author":"Bonen","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R077693_bib29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0009-3084(94)90132-5","article-title":"Oleate stimulates the formation of triglyceride-rich particles containing apoB100-apo(a) in long-term primary cultures of human hepatocytes","volume":"67\u201368","author":"Edelstein","year":"1994","journal-title":"Chem. Phys. Lipids."},{"key":"10.1194\/jlr.R077693_bib30","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1161\/01.ATV.15.1.58","article-title":"C\/T polymorphism in the 5\u2032 untranslated region of the apolipoprotein(a) gene introduces an upstream ATG and reduces in vitro translation","volume":"15","author":"Zysow","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.R077693_bib31","series-title":"Drugs Affecting Lipid Metabolism","first-page":"161","article-title":"Metabolism of apo(a) and apoB-100 in human lipoprotein(a)","author":"Gaubatz","year":"1993"},{"key":"10.1194\/jlr.R077693_bib32","first-page":"3267","article-title":"Metabolism of Apo(a) and ApoB100 of lipoprotein(a) in women: effect of postmenopausal estrogen replacement","volume":"83","author":"Su","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1194\/jlr.R077693_bib33","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.atherosclerosis.2012.09.031","article-title":"In vivo stable-isotope kinetic study suggests intracellular assembly of lipoprotein(a)","volume":"225","author":"Frischmann","year":"2012","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.R077693_bib34","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0021-9150(00)00732-2","article-title":"The metabolism of lipoprotein(a) and other apolipoprotein B-containing lipoproteins: a kinetic study in humans","volume":"157","author":"Demant","year":"2001","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.R077693_bib35","doi-asserted-by":"crossref","first-page":"24369","DOI":"10.1016\/S0021-9258(18)35775-2","article-title":"Reconstitution of lipoprotein(a) by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein(a)","volume":"267","author":"Chiesa","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R077693_bib36","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1172\/JCI116927","article-title":"Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein (a)","volume":"92","author":"Linton","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R077693_bib37","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0022-2275(20)42055-3","article-title":"Relationship between apo[a] isoforms and Lp[a] density in subjects with different apo[a] phenotype: a study before and after a fatty meal","volume":"32","author":"Pfaffinger","year":"1991","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R077693_bib38","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1161\/ATVBAHA.115.306136","article-title":"Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus","volume":"35","author":"Ooi","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.R077693_bib39","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0009-3084(94)90129-5","article-title":"Triglyceride-rich lipoprotein interactions with Lp(a)","volume":"67\u201368","author":"McConathy","year":"1994","journal-title":"Chem. Phys. Lipids."},{"key":"10.1194\/jlr.R077693_bib40","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1172\/JCI112345","article-title":"Fat feeding in humans induces lipoproteins of density less than 1.006 that are enriched in apolipoprotein (a) and that cause lipid accumulation in macrophages","volume":"77","author":"Bersot","year":"1986","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R077693_bib41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0005-2760(79)90131-0","article-title":"Lipoprotein (a) is not a metabolic product of other lipoproteins containing apolipoprotein B","volume":"575","author":"Krempler","year":"1979","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.R077693_bib42","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1194\/jlr.R600013-JLR200","article-title":"What we have learned about VLDL and LDL metabolism from human kinetics studies","volume":"47","author":"Parhofer","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R077693_bib43","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1172\/JCI113259","article-title":"Suppression of apolipoprotein B production during treatment of cholesteryl ester storage disease with lovastatin. Implications for regulation of apolipoprotein B synthesis","volume":"80","author":"Ginsberg","year":"1987","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R077693_bib44","doi-asserted-by":"crossref","first-page":"323ra12","DOI":"10.1126\/scitranslmed.aad2195","article-title":"Complex effects of inhibiting hepatic apolipoprotein B100 synthesis in humans","volume":"8","author":"Reyes-Soffer","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1194\/jlr.R077693_bib45","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1172\/JCI109813","article-title":"Turnover of lipoprotein (a) in man","volume":"65","author":"Krempler","year":"1980","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R077693_bib46","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1172\/JCI110896","article-title":"Studies on the role of specific cell surface receptors in the removal of in man","volume":"71","author":"Krempler","year":"1983","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R077693_bib47","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0021-9150(91)90025-X","article-title":"Catabolism of lipoprotein(a) in familial hypercholesterolaemic subjects","volume":"87","author":"Knight","year":"1991","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.R077693_bib48","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.metabol.2004.10.001","article-title":"The metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein (a) in human beings","volume":"54","author":"Jenner","year":"2005","journal-title":"Metabolism."},{"key":"10.1194\/jlr.R077693_bib49","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.metabol.2015.10.031","article-title":"Distinct metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein(a)","volume":"65","author":"Diffenderfer","year":"2016","journal-title":"Metabolism."},{"key":"10.1194\/jlr.R077693_bib50","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1172\/JCI116221","article-title":"Variation in lipoprotein (a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein (a) production","volume":"91","author":"Rader","year":"1993","journal-title":"J. Clin. Invest ."},{"key":"10.1194\/jlr.R077693_bib51","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1172\/JCI117292","article-title":"The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate","volume":"93","author":"Rader","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R077693_bib52","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1172\/JCI80025","article-title":"Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects","volume":"125","author":"Millar","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R077693_bib53","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1161\/ATVBAHA.115.306680","article-title":"Cholesteryl ester transfer protein inhibition with anacetrapib decreases fractional clearance rates of high-density lipoprotein apolipoprotein A-I and plasma cholesteryl ester transfer protein","volume":"36","author":"Reyes-Soffer","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.R077693_bib54","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/CIRCULATIONAHA.116.025253","article-title":"Effects of PCSK9 inhibition with alirocumab on lipoprotein metabolism in healthy humans","volume":"135","author":"Reyes-Soffer","year":"2017","journal-title":"Circulation."},{"key":"10.1194\/jlr.R077693_bib55","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1172\/JCI200523219","article-title":"Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus","volume":"115","author":"Nagashima","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R077693_bib56","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1194\/jlr.M400108-JLR200","article-title":"A new combined multicompartmental model for apolipoprotein B-100 and triglyceride metabolism in VLDL subfractions","volume":"46","author":"Adiels","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R077693_bib57","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0022-2275(20)32577-3","volume":"39","author":"Berglund","year":"1998","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R077693_bib58","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/sj.ki.5002131","article-title":"In vivo turnover study demonstrates diminished clearance of lipoprotein(a) in hemodialysis patients","volume":"71","author":"Frischmann","year":"2007","journal-title":"Kidney Int."},{"key":"10.1194\/jlr.R077693_bib59","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0009-8981(87)90110-0","article-title":"Free and Apo B-associated Lpa-specific protein in human serum","volume":"164","author":"Gries","year":"1987","journal-title":"Clin. Chim. Acta."},{"key":"10.1194\/jlr.R077693_bib60","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1161\/01.ATV.16.8.905","article-title":"Urinary excretion of apo(a) fragments. Role in apo(a) catabolism","volume":"16","author":"Kostner","year":"1996","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.R077693_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1194\/jlr.R071571","article-title":"Lipoprotein (a): a historical appraisal","volume":"58","author":"Kostner","year":"2017","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R077693_bib62","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/01.ATV.20.2.522","article-title":"Lipoprotein(a) in homozygous familial hypercholesterolemia","volume":"20","author":"Kraft","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.R077693_bib63","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1399-0004.1981.tb01047.x","article-title":"Lp(a) lipoprotein enters cultured fibroblasts independently of the plasma membrane low density lipoprotein receptor","volume":"20","author":"Maartmann-Moe","year":"1981","journal-title":"Clin. Genet."},{"key":"10.1194\/jlr.R077693_bib64","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1172\/JCI114602","article-title":"Overexpression of human low density lipoprotein receptors leads to accelerated catabolism of Lp(a) lipoprotein in transgenic mice","volume":"85","author":"Hofmann","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R077693_bib65","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2362.1993.tb00966.x","article-title":"In vivo kinetics of lipoprotein(a) in homozygous Watanabe heritable hyperlipidaemic rabbits","volume":"23","author":"Liu","year":"1993","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1194\/jlr.R077693_bib66","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1172\/JCI117794","article-title":"The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans","volume":"95","author":"Rader","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R077693_bib67","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1194\/jlr.M500249-JLR200","article-title":"Lipoprotein [a] is cleared from the plasma primarily by the liver in a process mediated by apolipoprotein [a]","volume":"46","author":"Cain","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R077693_bib68","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s11745-999-0370-z","article-title":"Lipoprotein (a) metabolism estimated by nonsteady-state kinetics","volume":"34","author":"Parhofer","year":"1999","journal-title":"Lipids."},{"key":"10.1194\/jlr.R077693_bib69","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1194\/jlr.M060210","article-title":"Mechanistic insights into Lp(a)-induced IL-8 expression: a role for oxidized phospholipid modification of apo(a)","volume":"56","author":"Scipione","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R077693_bib70","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/CIRCRESAHA.116.308811","article-title":"PCSK9 association with lipoprotein(a)","volume":"119","author":"Tavori","year":"2016","journal-title":"Circ. Res."},{"key":"10.1194\/jlr.R077693_bib71","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1042\/CS20160403","article-title":"The complexity of lipoprotein (a) lowering by PCSK9 monoclonal antibodies","volume":"131","author":"Lambert","year":"2017","journal-title":"Clin. Sci."},{"key":"10.1194\/jlr.R077693_bib72","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1093\/clinchem\/35.10.2121","article-title":"Lp(a) lipoprotein concentration in serum of patients with heavy proteinuria of different origin","volume":"35","author":"Kar\u00e1di","year":"1989","journal-title":"Clin. Chem."},{"key":"10.1194\/jlr.R077693_bib73","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1093\/ndt\/gfg181","article-title":"Relationship of non-LDL-bound apo(a), urinary apo(a) fragments and plasma Lp(a) in patients with impaired renal function","volume":"18","author":"Cauza","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1194\/jlr.R077693_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2710.2011.01244.x","article-title":"Optimal therapy for reduction of lipoprotein(a)","volume":"37","author":"Lippi","year":"2012","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1194\/jlr.R077693_bib75","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1093\/eurheartj\/ehx033","article-title":"Lipoprotein(a): the revenant","volume":"38","author":"Gencer","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1194\/jlr.R077693_bib76","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jacc.2016.11.042","article-title":"A test in context: lipoprotein(a): diagnosis, prognosis, controversies, and emerging therapies","volume":"69","author":"Tsimikas","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1194\/jlr.R077693_bib77","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jprot.2014.04.030","article-title":"Absolute quantification of apolipoproteins and associated proteins on human plasma lipoproteins","volume":"106","author":"von Zychlinski","year":"2014","journal-title":"J. Proteomics."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002222752033947X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002222752033947X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.R077693","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T23:07:45Z","timestamp":1640041665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002222752033947X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":77,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S002222752033947X"],"URL":"https:\/\/doi.org\/10.1194\/jlr.r077693","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The metabolism of lipoprotein (a): an ever-evolving story","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1194\/jlr.R077693","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}